NYSE - Delayed Quote USD

CONMED Corporation (CNMD)

Compare
73.32 -1.42 (-1.90%)
At close: December 11 at 4:00:02 PM EST
73.32 0.00 (0.00%)
After hours: December 11 at 6:03:14 PM EST

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Curt R. Hartman President, CEO & Director 2.45M -- 1964
Mr. Todd W. Garner CPA Executive VP, CFO & Principal Accounting Officer 1.17M 1.21M 1969
Mr. Patrick J. Beyer Chief Operating Officer 1.6M -- 1966
Mr. Richard Glaze Chief Information Officer -- -- 1966
Hollie Foust General Counsel & Corporate Secretary -- -- --
Mr. Peter K. Shagory Executive Vice President of Strategy & Corporate Development -- -- 1969
Ms. Shanna L. Cotti-Osmanski Executive VP of Information Technology & CIO -- -- 1977
Mr. John Ferrell Executive Vice President of Human Resources -- -- 1968
Mr. David R. Murray President of ConMed Electrosurgery 469.17k -- 1948
Ms. Johonna Marie Pelletier CPA VP of Tax & Treasurer -- -- 1973

CONMED Corporation

11311 Concept Boulevard
Largo, FL 33773-4908
United States
727 392 6464 https://www.conmed.com
Sector: 
Healthcare
Industry: 
Medical Devices
Full Time Employees: 
4,000

Description

CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as provides supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. It markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. The company also provides battery-powered and autoclavable bone power tool systems for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries under Hall surgical brand name. In addition, it offers general surgery products, including clinical insufflation systems under AirSeal brand; smoke removal devices under Buffalo Filter brand; endomechanical products, such as tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors used in minimally invasive surgeries; and electrosurgical solution comprising monopolar and bipolar generators, argon beam coagulation generators, handpieces, smoke management systems and other accessories. Further, the company provides endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures, and products for the treatment of diseases of the dilatation, hemostasis, biliary, structure management, and infection prevention and patient monitoring, including ECG and EEG electrodes, and cardiac defibrillation pads. It markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.

Corporate Governance

CONMED Corporation’s ISS Governance QualityScore as of December 1, 2024 is 2. The pillar scores are Audit: 4; Board: 2; Shareholder Rights: 3; Compensation: 4.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

December 20, 2024 at 12:00 AM UTC

Ex-Dividend Date

January 29, 2025 at 10:59 AM UTC - February 3, 2025 at 12:00 PM UTC

CONMED Corporation Earnings Date

Recent Events

December 10, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

December 3, 2024 at 5:30 PM UTC

at Piper Sandler Healthcare Conference

November 20, 2024 at 11:00 AM UTC

at Jefferies London Healthcare Conference

November 19, 2024 at 1:35 PM UTC

at Stifel Healthcare Conference

October 31, 2024 at 12:00 AM UTC

10-Q: Periodic Financial Reports

October 30, 2024 at 8:30 PM UTC

Q3 2024 Earnings Call

October 30, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

October 4, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

October 4, 2024 at 12:00 AM UTC

Dividend Date

September 30, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

Related Tickers